Biocon to weigh early redemption of unlisted debentures

Biocon Limited will hold a board of directors meeting on October 1, 2025, to consider the early redemption of 1,07,000 unlisted, secured, rated, redeemable Non-Convertible Debentures (NCDs). Each NCD has a face value of INR 100,000. These debentures were originally issued and allotted by the company on a private placement basis on February 21, 2023.

The proposed early redemption is subject to the approval of the board of directors and other necessary regulatory approvals, with the final redemption date to be determined by the company. This intimation is being made in accordance with Regulation 29(1)(h) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Further information regarding this consideration will also be made available on the company's official website, www.biocon.com. The announcement was signed by Mukesh Kamath, interim chief financial officer, on September 28, 2025.